Status:

RECRUITING

Cognitive Remediation Therapy for Schizophrenia: Effects on EEG and Emotional Regulation

Lead Sponsor:

Beykoz University

Collaborating Sponsors:

Uskudar University

Istanbul Nisantasi University

Conditions:

Schizophrenia Disorders

Cognitive Dysfunction

Eligibility:

All Genders

18-55 years

Phase:

NA

Brief Summary

This study aims to determine whether Cognitive Remediation Therapy (CRT) can improve attention, memory, and emotional regulation in people with schizophrenia. CRT is a structured program that includes...

Detailed Description

This is a randomized controlled trial examining the effects of Cognitive Remediation Therapy (CRT) on neurophysiological and behavioral outcomes in schizophrenia. The primary goal is to assess whether...

Eligibility Criteria

Inclusion

  • Inclusion Criteria (Schizophrenia Group):
  • Diagnosed with schizophrenia according to DSM-5 criteria
  • Age between 18 and 55 years
  • Clinically stable (no hospitalization or medication change within 1 month)
  • Minimum primary school education
  • Able to provide informed consent
  • Right-handed (for EEG protocol consistency)
  • Inclusion Criteria (Healthy Control Group):
  • No history of psychiatric or neurological disorders
  • Age- and gender-matched to schizophrenia group
  • No current medication affecting CNS
  • Able to provide informed consent
  • Right-handed
  • Exclusion Criteria (Both Groups):
  • Current or past substance use disorder (within the past year)
  • Comorbid neurological illness (e.g., epilepsy, traumatic brain injury)
  • Current use of benzodiazepines or medications that significantly affect cognitive function
  • Intellectual disability or MoCA score \< 20
  • Visual or hearing impairments that could interfere with task performance
  • Participation in a psychological intervention in the last 3 months

Exclusion

    Key Trial Info

    Start Date :

    March 15 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    October 15 2025

    Estimated Enrollment :

    60 Patients enrolled

    Trial Details

    Trial ID

    NCT06936397

    Start Date

    March 15 2025

    End Date

    October 15 2025

    Last Update

    April 20 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Beykoz University

    Istanbul, Turkey (Türkiye), 34820